As of 2025-07-05, the Intrinsic Value of 89Bio Inc (ETNB) is -13.24 USD. This 89Bio valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.16 USD, the upside of 89Bio Inc is -230.35%.
Based on its market price of 10.16 USD and our intrinsic valuation, 89Bio Inc (ETNB) is overvalued by 230.35%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13.24 - -13.24 | -13.24 | -230.35% |
| P/E | (27.18) - (49.43) | (35.49) | -449.4% |
| DDM - Stable | (23.75) - (83.61) | (53.68) | -628.4% |
| DDM - Multi | (0.51) - (1.36) | (0.73) | -107.2% |
| Market Cap (mil) | 1,483.16 |
| Beta | 1.59 |
| Outstanding shares (mil) | 145.98 |
| Enterprise Value (mil) | 1,203.70 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.33% |
| Cost of Debt | 5.00% |
| WACC | 9.23% |